Loandepot, Inc. current report, 16 April 2024

loanDepot, Inc. Form 8-K Summary

Business Context and Reporting Period

loanDepot, Inc. filed a Form 8-K reporting that its indirect subsidiary, loanDepot.com, LLC, entered into Amendment No. 4 to its amended and restated master repurchase agreement with UBS AG on April 16, 2024. The agreement supports the sale and subsequent repurchase of certain residential mortgage loans. The report was signed on April 22, 2024.

Key Financial and Liquidity Terms

  • The aggregate repurchase facility amount was amended to $225 million.
  • The facility termination date was extended to April 15, 2025.
  • The amendment also changes provisions concerning eligible mortgage loan products.
  • The filing does not provide current revenue, profit, cash flow, margin, debt-balance, utilization, or liquidity figures.

Material Changes Versus the Prior Period

Compared with the existing agreement, Amendment No. 4 extends the facility maturity, establishes or revises the aggregate facility amount to $225 million, and modifies the types of mortgage loans eligible for financing. The filing does not disclose the prior facility amount or the specific product eligibility changes.

Outlook, Risks, Contingencies, and Unusual Items

The agreement provides financing capacity for mortgage loan inventory through a repurchase structure. Availability, borrowing costs, collateral eligibility, advance rates, margin requirements, covenants, and other detailed terms are not summarized in the filing text and should be reviewed in the complete amendment.

The filing does not provide management guidance or broader business outlook commentary. As with repurchase facilities generally, continued access may depend on compliance with contractual terms and the eligibility and valuation of pledged mortgage loans.

Important Facts to Verify

  • Review Exhibit 10.1 for the complete economic terms, including interest rates, advance rates, haircuts, covenants, events of default, and collateral requirements.
  • Confirm the extent of actual facility utilization and remaining borrowing capacity as of the reporting date.
  • Determine which mortgage loan products were added, removed, or otherwise modified under the eligibility provisions.
  • Verify whether the $225 million amount represents a committed facility limit, a maximum availability subject to conditions, or another aggregate measure.
  • Assess the April 15, 2025 termination provisions and any extension or renewal rights.